+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

ABO blood group, hypercoagulability, and cardiovascular and cancer risk

ABO blood group, hypercoagulability, and cardiovascular and cancer risk

Critical Reviews in Clinical Laboratory Sciences 49(4): 137-149

The antigens of the ABO system (A, B, and H determinants, respectively) consist of complex carbohydrate molecules. It has been known for nearly half a century that the ABO blood group exerts a major influence on plasma levels of the von Willebrand factor (VWF)-factor VIII (FVIII) complex and that normal group O individuals have significantly lower levels of VWF and FVIII than do non-O individuals. As a consequence, several investigators have studied the association between ABO blood group and the risk of developing bleeding or thrombotic events. A number of epidemiological studies have also analyzed the biologic relevance of this interaction by assessing whether the ABO blood group could influence human longevity through the regulation of VWF-FVIII plasma levels. In this review, the molecular mechanisms by which the ABO blood group determines plasma VWF and consequently, FVIII levels, the possible clinical implications, and the current knowledge on the association between the ABO blood group and the risk of developing certain cancers will be reviewed.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 051289813

Download citation: RISBibTeXText

PMID: 22856614

DOI: 10.3109/10408363.2012.708647

Related references

Self-related Health and Blood Hypercoagulability: A Possible Mechanism for Cardiovascular Risk. Thrombosis and Haemostasis 118(01): 004-005, 2018

Self-related Health and Blood Hypercoagulability: A Possible Mechanism for Cardiovascular Risk. Thrombosis and Haemostasis 118(1): 4-5, 2018

Hypercoagulability of the blood and cardiovascular thromboses during chronic respiratory insufficiency. Presse Med 72(6): 317-320, 1964

Hypertension, hypercoagulability and the metabolic syndrome: a cluster of risk factors for cardiovascular disease. Bio-Medical Materials and Engineering 22(1-3): 35-48, 2012

Abo blood group associations with cardiovascular risk factor variables ii. blood pressure obesity and their anthropometric covariables the bogalusa louisiana usa heart study. Human Biology 58(4): 549-584, 1986

Hypercoagulability preceding cancer. Does hypercoagulability awaken dormant tumor cells in the host?. Journal of Thrombosis and Haemostasis 3(3): 577-580, 2005

Cardiovascular risk reduction in high-risk pediatric patients - A scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research. Circulation 114(24): 2710-2738, 2006

Hypercoagulability preceding cancer. Venous thromboembolism and subsequent cancer risk. Journal of Thrombosis and Haemostasis 3(3): 583-584, 2005

ABO blood group is a cardiovascular risk factor in patients with familial hypercholesterolemia. Journal of Clinical Lipidology 12(2): 383-389.E1, 2018

Cardiovascular disease and ABO blood-groups in Africans. Are blood-group A individuals at higher risk of ischemic disease?: A pilot study. Egyptian Heart Journal 69(4): 229-234, 2018

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer-Associated Thrombosis: The Observational ROADMAP-CAT Study. Oncologist 23(11): 1372-1381, 2018

Lipoprotein(a) in children with hypercholesterolemia as a marker of the familial history of cardiovascular risk. The Working Group on Cardiovascular Risk Factors in Childhood and Adolescence. Anales Espanoles de Pediatria 45(1): 53-56, 1996

Distribution of ABO blood group and major cardiovascular risk factors with coronary heart disease. Biomed Research International 2013: 782941, 2014

Discordance between ambulatory versus clinic blood pressure according to global cardiovascular risk group. Korean Journal of Internal Medicine 30(5): 610-619, 2016

Blood hypercoagulability as a risk factor for leg ulcers in sickle cell disease. Blood 75(12): 2467-2468, 1990